- Home
- CRBP vs PLCE Comparison
CRBP vs PLCE Comparison
Compare CRBP & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- PLCE
- Stock Information
- Founded
- CRBP 2009
- PLCE 1969
- Country
- CRBP United States
- PLCE United States
- Employees
- CRBP 19
- PLCE N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- PLCE Clothing/Shoe/Accessory Stores
- Sector
- CRBP Health Care
- PLCE Consumer Discretionary
- Exchange
- CRBP Nasdaq
- PLCE Nasdaq
- Market Cap
- CRBP 158.3M
- PLCE 170.7M
- IPO Year
- CRBP N/A
- PLCE 1997
- Fundamental
- Price
- CRBP $13.00
- PLCE $10.54
- Analyst Decision
- CRBP Strong Buy
- PLCE Hold
- Analyst Count
- CRBP 8
- PLCE 3
- Target Price
- CRBP $62.00
- PLCE $11.00
- AVG Volume (30 Days)
- CRBP 313.3K
- PLCE 510.9K
- Earning Date
- CRBP 11-07-2024
- PLCE 12-03-2024
- Dividend Yield
- CRBP N/A
- PLCE N/A
- EPS Growth
- CRBP N/A
- PLCE N/A
- EPS
- CRBP N/A
- PLCE N/A
- Revenue
- CRBP N/A
- PLCE $1,432,740,000.00
- Revenue This Year
- CRBP N/A
- PLCE N/A
- Revenue Next Year
- CRBP N/A
- PLCE N/A
- P/E Ratio
- CRBP N/A
- PLCE N/A
- Revenue Growth
- CRBP N/A
- PLCE N/A
- 52 Week Low
- CRBP $5.25
- PLCE $4.77
- 52 Week High
- CRBP $61.90
- PLCE $38.03
- Technical
- Relative Strength Index (RSI)
- CRBP 25.10
- PLCE 36.88
- Support Level
- CRBP $12.90
- PLCE $10.10
- Resistance Level
- CRBP $16.21
- PLCE $12.62
- Average True Range (ATR)
- CRBP 0.95
- PLCE 1.44
- MACD
- CRBP -0.16
- PLCE -0.37
- Stochastic Oscillator
- CRBP 1.69
- PLCE 5.49
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It design, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names.